Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

FIRST CHOICE URGENT CARE LLC

NPI: 1023328978 · COLLIERVILLE, TN 38017 · Primary Care Clinic/Center · NPI assigned 10/13/2010

$483K
Total Medicaid Paid
31,149
Total Claims
22,867
Beneficiaries
31
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialLUCAS, CHRISTY (OWNER)
NPI Enumeration Date10/13/2010

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 4,935 $69K
2019 6,070 $100K
2020 3,270 $69K
2021 4,180 $80K
2022 6,504 $101K
2023 5,584 $56K
2024 606 $8K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 5,021 3,740 $188K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,371 1,886 $55K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 482 322 $41K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 692 459 $32K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 5,765 4,268 $28K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 688 458 $23K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 226 205 $16K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 735 545 $16K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,617 1,008 $15K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,129 502 $11K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 267 225 $8K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 60 54 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 619 557 $6K
36416 4,469 3,269 $5K
87634 240 95 $5K
81025 1,128 911 $5K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 136 113 $5K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 223 191 $5K
81002 2,218 1,765 $4K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 100 86 $3K
36415 Collection of venous blood by venipuncture 1,388 1,051 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 108 102 $1K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 35 28 $881.33
87400 55 39 $366.33
85027 157 89 $348.68
J1100 Injection, dexamethasone sodium phosphate, 1 mg 418 294 $197.76
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 14 12 $88.03
J0696 Injection, ceftriaxone sodium, per 250 mg 85 40 $40.23
81003 129 63 $14.45
87999 539 474 $14.30
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 35 16 $6.11